Increased prospective cardiovascular disease risk in 127,517 Nordic women with polycystic ovary syndrome. A national cohort study [0.03%]
一项全国队列研究：在127,517名北欧多囊卵巢综合征女性中预期心血管疾病风险增加
Dorte Glintborg,Meri-Maija Ollila,Noona Koskenkari et al.
Dorte Glintborg et al.
Background: Cardiovascular disease (CVD) risk factors are prevalent in women with PCOS, but prospective data regarding CVD in population-based cohorts are limited. ...
Continuous Subcutaneous Administration of Teriparatide as a therapeutic option in Chronic Hypoparathyroidism: retrospective study in three Tertiary Care Centers of the Epi-Hypo study [0.03%]
长效甲状旁腺激素皮下持续输注治疗慢性低血钙症：Epi-Hypo研究中三个三级医疗中心的回顾性分析
Amina Attia,Mathilde Brière,Peter Kamenicky et al.
Amina Attia et al.
Context: Chronic hypoparathyroidism (cHP) is a rare endocrine disorder characterized by an hypocalcemia secondary to the insufficient secretion of the parathyroid hormone. Despite the good observance of oral treatment wit...
Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in patients with CKD [0.03%]
用于CKD患者的血管紧张素生成酶抑制的vicadrostat药理学研究
Isabella A Gashaw,Katherine R Tuttle,Manuel Monroy Kuhn et al.
Isabella A Gashaw et al.
Objective: Aldosterone synthase inhibition may affect cortisol synthesis due to homology between CYP11B2 (aldosterone synthase) and CYP11B1. The selectivity of vicadrostat, a highly selective aldosterone synthase inhibito...
"Albumin-adjusted" calcemia: time to move on for chronic hypoparathyroidism patients? [0.03%]
调整血清白蛋白后的钙水平：是时候为慢性低甲状旁腺功能患者采取行动了吗？
Jean-Philippe Bertocchio,Akram Hecini,Cécile Ghander
Jean-Philippe Bertocchio
Use of total calcium in hypoparathyroidism: A pragmatic approach but with limitations [0.03%]
低甲状旁腺素血症全钙使用的务实方法及其局限性
Stefan Pilz,Ottilia Buch,Luís Miguel Cardoso et al.
Stefan Pilz et al.
Real-World Efficacy and Safety of Selpercatinib in RET-Mutant Medullary Thyroid Cancer at a Tertiary Referral Center [0.03%]
selpercitinib治疗RET突变型甲状腺髓样癌真实世界中的疗效和安全性
Yara Maria Machlah,Lynn Marlene Srasra,Sarah Theurer et al.
Yara Maria Machlah et al.
Objective: Selective RET inhibition with selpercatinib significantly improved outcomes in advanced RET-mutant medullary thyroid cancer (MTC). However, data from endocrine oncology practice are limited, particularly in het...
Mild Hyponatremia in Hospitalized Patients: Revisiting Bone Turnover and Clinical Implications [0.03%]
住院患者的轻度低钠血症：重新审视骨转换及临床意义
Wei Lu,Chenchen Zhang,Hanning Zhang
Wei Lu
Duration of Adrenal Insufficiency after Surgical Treatment of Endogenous Hypercortisolism: A Prospective Cohort Study [0.03%]
原发性皮质醇增多症手术治疗后肾上腺功能不全持续时间的前瞻性队列研究
Shireen R Chacko,Sarina Ahmadian,Shubhangi Sharma Sharma et al.
Shireen R Chacko et al.
Objective: Evidence on the duration of post-operative adrenal insufficiency (AI) in patients with endogenous hypercortisolism is scarce. We sought to determine the duration of post-operative AI and to identify factors ass...
Rising Burden of PRL-PitNETs: Patterns Across Tumour Sizes and Incidentalomas [0.03%]
PRL-PitNETs的负担日益加重：不同肿瘤大小和偶然发现的模式分析
Frederik Østergaard Klit,Sara Faartoft Nørgård,Anna-Sofie Dam Berrett et al.
Frederik Østergaard Klit et al.
Objective: Epidemiology of prolactin-secreting pituitary neuroendocrine tumours (PRL-PitNETs) remains scarce and inconsistent. It is a heterogeneous disease regarding age at onset, sex, and tumour characteristics. We aime...